Tumor

Researchers have found that adding a booster protein can significantly improve the outcome of cancer immunotherapy. Tests in mice showed the protein produced 10,000 times more cancer-targeting immune cells, with all mice surviving the experiment.

A new study has demonstrated how nanoparticles can be used as a type of mechanical drug inside cells to impair function and cause their demise, which could be used to target cancer while leaving healthy cells unharmed.

Scientists exploring the potential of spider silk in next-generation cancer therapies have found yet another use for the natural material, using it to stabilize and enhance a cancer-killing protein known as the "guardian of the genome."

Modifications to an existing drug promise to avoid toxic side effects brought on when treating a common and deadly form of cancer, with the scientists hailing the breakthrough as a potential "home run" for next-generation treatments.

Researchers at the Tokyo University of Science have demonstrated a low-cost and highly promising form of nanoparticle technology, using corn and water as a starting point for a novel "bionanoparticle" that suppresses tumor growth in mice.

Heightened tissue growth can result when cells come under tension, and a new study on cancer cells has pinpointed the biological mechanism that drives this process, which the authors believe can be targeted to prevent tumor development.

A new study has turned up a new target in efforts to tackle metastatic cancers, the primary cause of death from the disease, by unearthing a protein that prevents cells from migrating to other parts of the body by sticking them to surrounding tissue.

Immunotherapy is a promising new form of cancer treatment, but the supercharged immune cells it employs can become exhausted in the fight. Researchers in Japan have found a way to keep them going for longer, by rejuvenating them with stem cells.

Scientists have known for some time that lactic acid can fuel the growth of tumors, and a new study has drilled into the matter and turned up some useful insights that could lead to new and improved forms of immunotherapy to combat cancer.

A novel device developed at Northwestern can sort and multiply immune cells harvested from tumors with great efficiency, creating armies of personalized cancer-killing cells that have been deployed to induce dramatic tumor shrinkage in mice.

Scientists have developed an advanced new brain sensor that promises to take the safety and efficiency of cancer and epilepsy treatment into new terrain, by recording electrical signals in record-breaking resolution.

MIT scientists have developed a new technique to jump-start the body's immune system with the help of injured cancerous cells, with the approach shown to be capable of completely eliminating tumors in mouse models of the disease.